Condition: Cervical Cancer · Proton Therapy · Radiotherapy Side Effect · Sponsor: University of Aarhus
The purpose of this protocol is to determine toxicity and efficacy of proton therapy in combination with standard concomitant platinum-based chemotherapy and standard image-guided adaptive brachytherapy (IGABT) in patients with locally advanced cervical cancer (LACC). The over-all aim is to maintain a high disease control and at the same time reduce acute morbidity as well as late side effects after treatment.
This description comes directly from the study's public registry record.
Hanne Matthiesen, MD, PhD · 004592432356 · hanne.from.mathiesen@regionh.dk
Camilla Kronborg, MD, PhD · 004592432356 · camkro@rm.dk
Always discuss trial participation with your own doctor first.
| Department of Oncology, Capital Region Denmark | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06462378